Exagen (XGN) Shows Fast-paced Momentum But Is Still a Bargain Stock

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point, as stocks may lose momentum when their valuations exceed future growth potential [2] - Investing in bargain stocks that have recently shown price momentum can be a safer strategy [3] Group 2: Exagen Inc. (XGN) Performance - Exagen Inc. (XGN) has seen a price increase of 55.2% over the past four weeks, indicating growing investor interest [4] - The stock gained 60% over the past 12 weeks, with a beta of 1.28, suggesting it moves 28% higher than the market [5] - XGN has a Momentum Score of A, indicating a favorable time to invest [6] Group 3: Earnings Estimates and Valuation - An upward trend in earnings estimate revisions has contributed to XGN earning a Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - XGN is trading at a Price-to-Sales ratio of 0.96, suggesting it is reasonably valued at 96 cents for each dollar of sales [7] Group 4: Additional Investment Opportunities - Besides XGN, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - The Zacks Premium Screens offer over 45 different strategies to help identify potential winning stocks [9]